Downregulation of adenylylcyclase types V and VI mRNA levels in pacing-induced heart failure in dogs

J Clin Invest. 1994 May;93(5):2224-9. doi: 10.1172/JCI117219.

Abstract

We have shown that the heart expresses two distinct forms of adenylylcyclase mRNA, types V and VI. In this study we have characterized the expression of these two mRNA species in heart failure generated by overdrive pacing at a rate of 240 beats/min. After 4 wk, left ventricular end-diastolic pressure and heart rate increased significantly with the appearance of signs of heart failure, i.e., edema, ascites, and exercise intolerance. Basal as well as forskolin-stimulated adenylylcyclase activities decreased significantly, which was accompanied by a reduction in the steady state mRNA levels of adenylylcyclase types V and VI. These data suggest that in this model of cardiomyopathy, the downregulation of adenylylcyclase catalytic activity results, at least in part, from a reduction in the steady state levels of types V and VI adenylylcyclase mRNA levels.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenylyl Cyclases / genetics*
  • Animals
  • Dogs
  • Down-Regulation*
  • Female
  • Heart Failure / enzymology*
  • Heart Rate
  • Humans
  • Isoenzymes / genetics*
  • Male
  • Myocardium / cytology
  • Myocardium / enzymology
  • RNA, Messenger / biosynthesis*
  • Receptors, Adrenergic, beta / physiology
  • Tissue Distribution

Substances

  • Isoenzymes
  • RNA, Messenger
  • Receptors, Adrenergic, beta
  • Adenylyl Cyclases